Page 2 - Trinity Biomedical Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

An ambitious academic, clinical and industry research programme that will provide new insights in our understanding of Motor Neuron Disease (MND), also known as Amyotrophic Lateral Sclerosis (ALS), was launched in Trinity today by Tánaiste and Minist

The programme will result in advanced data-driven prediction models for progression of the disease in patients and next-generation data analysis that facilitates clinical insights and treatment. This unique programme brings together clinicians, computer scientists, information engineers, technologists, and data scientists.

The SARM1 gene is a key driver in the damage that ultimately leads to impaired vision

The research suggests therapies targeting a gene could lead to new treatment options for many forms of blindness.